Arulampalam Velmurugesan, Greicius Gediminas, Pettersson Sven
Microbiology Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden.
Curr Opin Gastroenterol. 2006 Jul;22(4):349-53. doi: 10.1097/01.mog.0000231806.65030.ed.
The open ecosystem of the alimentary tract, harboring approximately 1 kg of bacteria, exhibits a rapid, but tightly controlled turnover. Impaired nuclear receptor function can give rise to perturbation in the gut, leading to inflammation and possibly neoplasia. Intriguingly, bacteria-dependent signaling pathways can modulate, and in turn be modulated by, a subset of nuclear receptors. This review attempts to highlight how microbes and nuclear receptors could jointly regulate gut homeostasis.
Commensal bacteria can utilize peroxisome proliferator activated receptor-gamma-dependent nuclear export of RelA as a novel mechanism to attenuate inflammatory signals triggered by a pathogen. Other nuclear receptors, such as liver X receptor, vitamin D receptor and farnesoid X receptor were also recently shown to interact with bacteria-induced mammalian inflammatory pathways. Although details of this interplay are still being unraveled, a role for these and other nuclear receptors in gastrointestinal inflammation and possibly neoplasia is beyond dispute.
The commensal microflora is being accorded due importance in regulating homeostasis of the gastrointestinal tract. Recent data suggest that the molecular messengers used by these bacteria include nuclear receptors. Exploiting mechanisms of nuclear receptor activity as drug targets, together with a detailed knowledge of the microbiota, could improve our understanding of gut-related ailments, and aid in mitigating their symptoms.
消化道的开放生态系统中寄居着约1千克细菌,其细菌周转迅速但受到严格调控。核受体功能受损可导致肠道紊乱,引发炎症并可能导致肿瘤形成。有趣的是,细菌依赖的信号通路可调节一部分核受体,反过来也会受到这些核受体的调节。本综述旨在强调微生物与核受体如何共同调节肠道稳态。
共生细菌可利用过氧化物酶体增殖物激活受体γ依赖的RelA核输出,作为减弱病原体触发的炎症信号的新机制。其他核受体,如肝X受体、维生素D受体和法尼醇X受体,最近也被证明与细菌诱导的哺乳动物炎症通路相互作用。尽管这种相互作用的细节仍在研究中,但这些核受体及其他核受体在胃肠道炎症乃至肿瘤形成中的作用是毋庸置疑的。
共生微生物群在调节胃肠道稳态方面的重要性正得到应有的重视。最近的数据表明,这些细菌使用的分子信使包括核受体。将核受体活性机制作为药物靶点,同时深入了解微生物群,可能会增进我们对肠道相关疾病的认识,并有助于缓解其症状。